Cellular pharmacokinetics of the novel biaryloxazolidinone radezolid in phagocytic cells: Studies with macrophages and polymorphonuclear neutrophils

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 6, 2010, Pages 2540-2548

  Lemaire, Sandrine ^a   Tulkens, Paul M ^a   Van Bambeke, Françoise ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; LACTATE DEHYDROGENASE; OXAZOLIDINONE DERIVATIVE; RADEZOLID; RX 1741; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL LEVEL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFUSION; DRUG ACCUMULATION; DRUG HALF LIFE; DRUG UPTAKE; HUMAN; HUMAN CELL; LYSOSOME; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PH; PRIORITY JOURNAL; TRANSPORT KINETICS;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CULTURE MEDIA; HALF-LIFE; HUMANS; HYDROGEN-ION CONCENTRATION; IONOPHORES; MACROPHAGES; MICE; MONENSIN; NEUTROPHILS; OXAZOLIDINONES; PHAGOCYTES; PROTEIN BINDING; TEMPERATURE;

EID: 77952633473     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01723-09     Document Type: Article

References (50)

1. Aubert-Tulkens, G., F. Van Hoof, and P. Tulkens. 1979. Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts. Quantitative ultra-structural and biochemical study. Lab. Invest. 40:481-491.
2. Barcia-Macay, M., F. Mouaden, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2008. Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts). J. Antimicrob. Chemother. 61:1288-1294.
3. Barcia-Macay, M., C. Seral, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2006. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob. Agents Chemother. 50:841-851.
4. Buerger, C., N. Plock, P. Dehghanyar, C. Joukhadar, and C. Kloft. 2006. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis. Antimicrob. Agents Chemother. 50:2455-2463.
5. Camenisch, G., J. Alsenz, H. van de Waterbeemd, and G. Folkers. 1998. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. Eur. J. Pharm. Sci. 6:317-324.
6. Carlier, M. B., I. Garcia-Luque, J. P. Montenez, P. M. Tulkens, and J. Piret. 1994. Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture. Int. J. Tissue React. 16:211-220.
7. Carlier, M. B., B. Scorneaux, A. Zenebergh, J. F. Desnottes, and P. M. Tulkens. 1990. Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages. J. Antimicrob. Chemother. 26(Suppl. B):27-39.
8. Carlier, M. B., A. Zenebergh, and P. M. Tulkens. 1987. Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells. J. Antimicrob. Chemother. 20(Suppl. B):47-56.
9. Carryn, S., S. Van de Velde, F. Van Bambeke, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2004. Impairment of growth of Listeria monocytogenes in THP-1 macrophages by granulocyte macrophage colony-stimulating factor: release of tumor necrosis factor-alpha and nitric oxide. J. Infect. Dis. 189: 2101-2109.
10. Clement, S., P. Vaudaux, P. Francois, J. Schrenzel, E. Huggler, S. Kampf, C. Chaponnier, D. Lew, and J. S. Lacroix. 2005. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J. Infect. Dis. 192:1023-1028.
11. de Duve, C., T. de Barsy, B. Poole, A. Trouet, P. Tulkens, and F. Van Hoof. 1974. Commentary. Lysosomotropic agents. Biochem. Pharmacol. 23:2495-2531.
12. File, T., Jr., F. Bagheri, L. Bush, J. Desanto, A. Markowitz, J. Pullman, R. Topkis, E. Burak, and S. Hopkins. 2008. A phase 2 study comparing two doses of radezolid to linezolid in adults with uncomplicated skin and skin structure infections (uSSSI), poster L-1515c. Abstr. 48th Annu. Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC)-Infect. Dis. Soc. Am. (IDSA) 46th Annu. Meet. American Society for Microbiology and Infectious Diseases Society of America, Washington, DC.
13. Gladue, R. P., and M. E. Snider. 1990. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob. Agents Chemother. 34: 1056-1060.
14. Honeybourne, D., C. Tobin, G. Jevons, J. Andrews, and R. Wise. 2003. Intrapulmonary penetration of linezolid. J. Antimicrob. Chemother. 51:1431-1434.
15. Jing, H., X. Luo, K. Harrington, J. Sutcliffe, and E. Burak. 2005. The pharmacokinetics of designer oxazolidinones in Sprague-Dawley rats, poster F-1261. 45th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
16. Kallinteri, P., and S. G. Antimisiaris. 2001. Solubility of drugs in the presence of gelatin: effect of drug lipophilicity and degree of ionization. Int. J. Pharm. 221:219-226.
17. Lawrence, L., P. Danese, J. DeVito, F. Franceschi, and J. Sutcliffe. 2008. In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens. Antimicrob. Agents Chemother. 52:1653-1662.
18. Lemaire, S., K. Kosowska-Shick, P. C. Appelbaum, G. Verween, P. M. Tulkens, and F. Van Bambeke. 2010. Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila. Antimicrob. Agents Chemother. 54:2549-2559.
19. Lemaire, S., F. Van Bambeke, P. C. Appelbaum, and P. M. Tulkens. 2009. Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines. J. Antimicrob. Chemother. 64:1035-1043.
20. Lemaire, S., F. Van Bambeke, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2007. Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and Madin-Darby canine kidney cells. Antimicrob. Agents Chemother. 51:2748-2757.
21. Lemaire, S., F. Van Bambeke, and P. M. Tulkens. 2009. Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages. Antimicrob. Agents Chemother. 53:3734-3743.
22. Lipinski, C. A., F. Lombardo, B. W. Dominy, and P. J. Feeney. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46: 3-26.
23. Lowy, F. D. 2000. Is Staphylococcus aureus an intracellular pathogen? Trends Microbiol. 8:341-343.
24. Luo, Y., and M. E. Dorf. 1997. Isolation of mouse neutrophils. Curr. Protoc. Immunol. 3:20.1-20.6.
25. Martinez, M. N., and G. L. Amidon. 2002. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J. Clin. Pharmacol. 42:620-643.
26. McKee, E. E., M. Ferguson, A. T. Bentley, and T. A. Marks. 2006. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob. Agents Chemother. 50:2042-2049.
27. Michot, J. M., F. Van Bambeke, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2004. Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter. Antimicrob. Agents Chemother. 48:2673-2682.
28. Montenez, J. P., F. Van Bambeke, J. Piret, A. Schanck, R. Brasseur, P. M. Tulkens, and M. P. Mingeot-Leclercq. 1996. Interaction of the macrolide azithromycin with phospholipids. II. Biophysical and computer-aided conformational studies. Eur. J. Pharmacol. 314:215-227.
29. Morgan, D. M. 1998. Tetrazolium (MTT) assay for cellular viability and activity. Methods Mol. Biol. 79:179-183.
30. Pascual, A., S. Ballesta, I. Garcia, and E. J. Perea. 2002. Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells. Antimicrob. Agents Chemother. 46:4013-4015.
31. Racher, A. J., D. Looby, and J. B. Griffiths. 1990. Use of lactate dehydrogenase release to assess changes in culture viability. Cytotechnology 3:301-307.
32. Renard, C., H. J. Vanderhaeghe, P. J. Claes, A. Zenebergh, and P. M. Tulkens. 1987. Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages. Antimicrob. Agents Chemother. 31:410-416.
33. Schentag, J. J., and C. H. Ballow. 1991. Tissue-directed pharmacokinetics. Am. J. Med. 91:5S-11S.
34. Seral, C., J. M. Michot, H. Chanteux, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2003. Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages. Antimicrob. Agents Chemother. 47:1047-1051.
35. Skripkin, E., T. S. McConnell, J. DeVito, L. Lawrence, J. A. Ippolito, E. M. Duffy, J. Sutcliffe, and F. Franceschi. 2008. R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance. Antimicrob. Agents Chemother. 52:3550-3557.
36. Steinman, R. M., S. E. Brodie, and Z. A. Cohn. 1976. Membrane flow during pinocytosis. A stereologic analysis. J. Cell Biol. 68:665-687.
37. Tartakoff, A. M. 1983. Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell 32:1026-1028. (Pubitemid 13033044)
38. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer. 26:171-176.
39. Tulkens, P. M., and A. Trouet. 1978. The uptake and intracellular accumulation of aminoglycoside antibiotics in lysosomes of cultured rat fibroblasts. Biochem. Pharmacol. 27:415-424.
40. Tyteca, D., P. Van Der Smissen, F. Van Bambeke, K. Leys, P. M. Tulkens, P. J. Courtoy, and M. P. Mingeot-Leclercq. 2001. Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts. Eur. J. Cell Biol. 80:466-478.
41. Van Bambeke, F., M. Barcia-Macay, S. Lemaire, and P. M. Tulkens. 2006. Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr. Opin. Drug Discov. Devel. 9:218-230.
42. Van Bambeke, F., S. Carryn, C. Seral, H. Chanteux, D. Tyteca, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2004. Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages. Antimicrob. Agents Chemother. 48: 2853-2860.
43. Van Bambeke, F., J. P. Montenez, J. Piret, P. M. Tulkens, P. J. Courtoy, and M. P. Mingeot-Leclercq. 1996. Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity. Eur. J. Pharmacol. 314:203-214.
44. Vara Prasad, J. V. 2007. New oxazolidinones. Curr. Opin. Microbiol. 10: 454-460.
45. Waddell, W. J., and R. G. Bates. 1969. Intracellular pH. Physiol. Rev. 49: 285-329.
46. Wilcox, M. H. 2005. Update on linezolid: the first oxazolidinone antibiotic. Expert Opin. Pharmacother. 6:2315-2326.
47. Yunis, A. A., U. S. Smith, and A. Restrepo. 1970. Reversible bone marrow suppression from chloramphenicol. A consequence of mitochondrial injury. Arch. Intern. Med. 126:272-275.
48. Zhanel, G. G., C. Shroeder, L. Vercaigne, S. Gin, J. Embil, and J. Hoban. 2001. A critical review of oxazolidinones: an alternative or replacement for glycopeptides and streptogramins? Can. J. Infect. Dis. 12:379-390.
49. Zhou, J., A. Bhattacharjee, S. Chen, Y. Chen, E. Duffy, J. Farmer, J. Goldberg, R. Hanselmann, J. A. Ippolito, R. Lou, A. Orbin, A. Oyelere, J. Salvino, D. Springer, J. Tran, D. Wang, Y. Wu, and G. Johnson. 2008. Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics. Bioorg. Med. Chem. Lett. 18:6175-6178.
50. Zhou, J., A. Bhattacharjee, S. Chen, Y. Chen, E. Duffy, J. Farmer, J. Goldberg, R. Hanselmann, J. A. Ippolito, R. Lou, A. Orbin, A. Oyelere, J. Salvino, D. Springer, J. Tran, D. Wang, Y. Wu, and G. Johnson. 2008. Design at the atomic level: generation of novel hybrid biaryloxazolidinones as promising new antibiotics. Bioorg. Med. Chem. Lett. 18:6179-6183.